Skip to main content

Aphria Set To Be Shoppers Drug Mart's Cannabis Supplier With New Agreement

VANCOUVER - Marijuana producer Aphria Inc. announced it has entered a five-year agreement to supply pharmacy chain Shoppers Drug Mart with medical cannabis.

The company said Monday that it will provide the pharmacy with four strains of dried marijuana flower in two different sizes and four cannabis oils. All 12 products will carry the Aphria brand name.

Aphria set to be Shoppers Drug Mart's cannabis supplier with new agreement Back to video

The deal comes after many months of discussions and is subject to Health Canada approving the application of the chain’s parent company, Loblaw Companies Ltd. (TSX:L), to dispense medical marijuana. Loblaw applied for a licence in October 2016, but neither company can say if or when that application will be approved.

Article content If granted, Aphria (TSX:APH) said it expects Shoppers Drug Mart will sell Aphria-branded cannabis products online. Current federal regulations allow licensed producers to distribute medical marijuana direct to consumers by mail.

The agreement is expected to have a positive material impact on Aphria’s medical sales revenue, said Aphria CEO Vic Neufeld during a conference call with analysts shortly after the news was announced.

“We have an opportunity to grow as Shoppers Drug Mart grows,” he said, adding Aphria’s committed to not entering discussions or making any business transactions with other national pharmacy banners in excess of a certain size.

If the federal government changes the rules to allow pharmacies to dispense medical marijuana in stores, Neufeld said, “the home run turns into a grand slam.”

Article content The company’s stock closed nearly two per cent higher on the Toronto Stock Exchange on Monday. It gained 22 cents to $11.62.

Aphria is one of several voices advocating for pharmacies to be permitted to distribute medical cannabis.

Loblaw has previously said it believes pharmacists and pharmacies should play a role in medical marijuana distribution, and posted a job ad for a medical marijuana brand manager as Shoppers Drug Mart last month.

“We have been very transparent in our view,” said Catherine Thomas, a spokeswoman, in an email.

“As the federal and provincial governments finalize their respective cannabis frameworks, we remain optimistic that they will allow pharmacists in stores, in communities to apply their professional care to medical cannabis patients.”

Article content The Aphria deal is one of several recent agreements between marijuana producers and pharmacies.

Maricann Group Inc. announced last month it entered into a letter of intent with Lovell Drugs Ltd. to be its primary and exclusive provider of medical cannabis. Lovell Drugs has a dozen pharmacies across Ontario.

Earlier this year, CanniMed Therapeutics Inc. signed a letter of intent with member-owned co-operative PharmaChoice to be its exclusive medical cannabis distributor and to train its pharmacists and pharmacy technicians. The deal is on hold until the first legislation change that allows pharmacies to distribute medical cannabis and will be completed within 60 days of that change.

Comments

Post a Comment

Popular posts from this blog

Medical Marijuana Card Doctors

How long have you been in business? We have been helping patients get their medical marijuana cards since 2012. The Hollywood Easy Clinic are medical marijuana card doctors in Los Angeles, New York City, Miami, Tampa & online. The Medical Marijuana Card Doctors at Hollywood Easy Clinic have the most experienced doctors. Hollywood Easy Clinic specializes in medical marijuana evaluations, emotional support animal evaluations and for growing marijuana cultivation licenses. Furthermore we are also able to perform medical marijuana renewals online. We bring years of trust and happy patients with no hidden fees unlike most doctors offices. Our medical marijuana doctors see patients with any debilitating medical condition. Most noteworthy you might have noticed that multiple medical marijuana doctors offices in Los Angeles have been closing. The main reason that they are closing these offices is due to unlicensed individuals owning them. Furthermore our medical marijuana docto

Differences Between Cancer Patients And Others Who Use Medicinal Cannabis

Differences between patients with cancer and those who do not have cancer who are seeking Cannabis are not well understood, but more information on the differences between these two groups is needed to support ongoing research efforts and policy decisions. Using a survey-based approach, we characterized groups of adults seeking medical Cannabis certification who did and did not have cancer. These data revealed that adults with cancer have multiple features that distinguish them from other adults seeking medical Cannabis certification. These differences fall into four main areas: (1) demographics, (2) symptoms and functioning, (3) Cannabis use characteristics (frequency/amount and mode of administration), and (4) certification-related differences. We will review each of these in the following paragraphs. Several demographic differences were noted in this study. These included the finding that those with cancer were older than those without cancer, in agreement with prior findings from a

Legal Weed Business Licenses As Low As $800

Wanna get in the NJ legal weed business? Here's how much it'll cost. We still don't know when legal weed sales in New Jersey will begin, but regulators on Thursday gave the public a look at how much it will cost to get in the business. The New Jersey Cannabis Regulatory Commission adopted its first set of rules and regulations governing the legal weed industry in the Garden State for at least the next year. The regulations don't yet answer a crucial question: When will someone be allowed to purchase legal weed at a licensed New Jersey dispensary without a medical marijuana card? Under the marijuana legalization laws enacted by Gov. Phil Murphy in February, the CRC must pick a start date in the next 180 days, about six months. But there is no timeline by which the CRC must issue licenses for cannabis businesses to begin sales. The commission, in its fourth month of operation, largely started from scratch when it was finally convened earlier this year. The C